Collaborations

RNA interference to be used in study of obesity and diabetes

Published in Obesity and Diabetes Week, February 2nd, 2004

The University of Massachusetts Medical School (UMMS) and Dharmacon, Inc., announced a collaboration to use RNA interference (RNAi) to study obesity and diabetes.

Dharmacon will design and supply siRNA reagents for studies that will be directed by Michael Czech, PhD, professor and chair molecular medicine, UMMS, to assess several thousand gene targets over a 3-year period.

"RNAi represents a potentially valuable new approach for unraveling the mechanisms underlying diseases like diabetes and obesity that are reaching epidemic proportions," said Czech.

"We expect Dharmacon's siRNA duplexes and reagents will give us the exceptional...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-02-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry